Notes - Segment Information

Astellas Pharma Inc. - Filing #7360307

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
Notes - Segment information
Segment information
Revenue
Revenue
1,518,619,000,000 JPY
1,296,163,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
1,260,000,000 JPY
489,000,000 JPY
Profit (loss) before tax
132,361,000,000 JPY
156,886,000,000 JPY
Assets
2,456,518,000,000 JPY
2,332,395,000,000 JPY
Investments accounted for using equity method
12,689,000,000 JPY
10,035,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.